The return of the Willem de Kooning painting "Woman-Ochre" to its place in the abstract expressionist collection at the UA Museum of Art was an unexpected highlight of 2017. (Photo: Bob Demers/UANews)
Dec. 18, 2017
The UA generated headlines across the globe in 2017, as evidenced by our UANews list of top 10 stories. From the installation of a new president to the improbable recovery of a priceless art masterpiece, it has been another remarkable year in Wildcat Country. (UANow will resume on Jan. 9.)
The three-story outpatient clinic (foreground) near North Campbell Avenue and East Allen Road will enhance the patient experience, according to Dr. Charles B. Cairns, dean of the College of Medicine – Tucson. (Photo: Matt George/Commotion Studios)
Dec. 14, 2017
The state-of-the-art facility, located east of the UA Cancer Center – North Campus, will have more than two dozen specialties available by mid-January. With UANews video.
The cantaloupe's rough skin makes an ideal surface on which microbes can find a home. (Photo: Brandon Quester/News21)
Dec. 11, 2017
With funding from the Department of Agriculture, researchers will develop new disinfectants, grow new breeds of melons, and educate farmers, retailers and consumers on safe practices.
Shannon Smith (left) and Alyssa Guido (Photo: Robin Tricoles/UANews)
Nov. 27, 2017
The Department of Emergency Medicine and the Division of Infectious Diseases have succeeded in making HIV screening a routine part of emergency department culture.
The Reglagene team, from left: Laurence Hurley, Vijay Gokhale and Richard Austin (Photo: Paul Tumarkin/Tech Launch Arizona)
Nov. 3, 2017
The UA has licensed a drug that aims to shorten the lives of cancer cells to startup Reglagene. The technology was invented at the College of Pharmacy and the BIO5 Institute.
May and Rajesh Khanna, inventors of the non-opioid drug candidates (Photo courtesy of Rajesh Khanna)
Nov. 1, 2017
Researchers in the College of Medicine – Tucson have invented a new class of non-opioid drug candidates to treat pain, and the UA has licensed the compounds.
Alzheimer's disease plaques (Image courtesy of ProNeurogen)
Oct. 26, 2017
Two patents have been awarded to the UA based on the novel approach of ProNeurogen to treating diseases causing memory loss and cognitive impairment.
Researchers in the lab of Dr. Janko Nikolich-Zugich at the UA (Photo: Robin Tricoles/UA News)
Oct. 23, 2017
What if you could experience full health until the very end of your life? UA researchers, led by Dr. Janko Nikolich-Zugich, think long-lasting immunity might be possible — if the thymus and the T-cells it produces to fight infection can be returned to greater efficiency. With UANews video.
Oct. 11, 2017
A carbon monoxide- and iron-based therapy, under development by the UA's Dr. Vance G. Nielsen, can inhibit venom's effects for up to an hour in animals. It eventually could be delivered with a device similar to an EpiPen autoinjector — and stocked on ambulances and in first-aid kits.